According to her past history, she had had no skin lesions since 2 years earlier, and hemoptysis occurred without any association with her menstrual cycle. Chest computed tomography showed residual ground-glass opacity in RLL due to aspirated blood, but no definite endobronchial lesion or vascular abnormality were observed as the cause of hemoptysis.
Chest X-ray showed no specific findings. The patient's blood test was normal except for a mild elevation of the erythrocyte sedimentation rate (29 mm/hr). For the differential diagnosis, anti-nuclear antibody, rheumatoid factor, serum complement levels (C3 and C4), and anti-neutrophil cytoplasmic antibodies (c-ANCA and p-ANCA) were tested; all of them showed negative results.
Elective bronchofiberscopy was scheduled in the operation room. During the exam, a small polyp was observed at the anterior basal segmental bronchus of the RLL and excisional biopsy was proceeded (Fig. 1) . After the excisional biopsy using laser, active bleeding occurred; therefore, emergent surgical resection was decided upon. in the hepatic artery, iliac artery, vena cava, cardiac chambers, femoral vein, iliac vein, and dural sinuses [2] . The patients may present cough, dyspnea, pulmonary hypertension, intracranial hypertension, fever, chills, chest pain, and hemoptysis [1, 3] . Laboratory findings are also not specific. The blood tests can show leukocytosis, elevated C-reactive protein, erythrocyte sedimentation rate, and anemia when hemoptysis or aneurysmal rupture occurs. Radiologic evaluations, including chest X-ray and chest computed tomography, could be useful only in few patients with large aneurysms.
Conventional angiography is regarded as a gold standard of pulmonary artery aneurysms [2] . However, when the patient has thrombosis in the vena cava and has a high risk of aneurysmal rupture, angiography should not be performed. Considering the histopathological findings, the medical management is similar in both diseases: steroids alone or in combination with immunosuppressants [5] . However, a standard treatment of HSS has not been established because of its unknown etiology. Surgical treatments are performed when massive hemoptysis originates from one segment or one lung.
Lobectomy or pneumonectomy could be performed to remove the aneurysm [1, 3] . However, in cases of extensive bilateral multiple aneurysms, operative treatments might be associated with high mortality and morbidity rates [1] . For these patients, transcatheter arterial embolization or immunosuppressive therapy might be an option [3] .
To conclude, BD and HSS are rare diseases that might be indistinguishable. Both diseases, however, are associated with high mortality because of the massive hemoptysis in the final stage. Therefore, early diagnosis and immediate surgical resection are crucial for prevention of disastrous complication and mortality. Further, as in this case, the surgical team should be well prepared since an invasive evaluation might cause unexpected complications when the patient is suspicious of pulmonary or bronchial artery aneurysm.
